Cardiac Defects in Neonates Born to Mothers with Gestational Diabetes Mellitus and their Association with Maternal Treatment Regime
Keywords:
Gestational diabetes, Echocardiography, Patent ductus arteriosus, Ventricular septal defectAbstract
Objective: To determine the type of cardiac anomalies on echocardiography in neonates delivered to mothers diagnosed with gestational diabetes mellitus (GDM) and evaluate the association of neonatal cardiac defects with maternal treatment during pregnancy.
Methodology: This cross-sectional study was conducted at the Department of Pediatrics, Ittefaq Trust Hospital, Lahore from August 2024 to January 2025 after ethical approval. A total of 108 neonates delivered to mothers with gestational diabetes were included using non-probability consecutive sampling technique. After taking informed consent from parents, they were screened by using echocardiography and neonatal cardiac anomalies were noted, if present. All the neonates with cardiac anomalies were followed-up in outpatient department (OPD) for spontaneous closure of defect for 3 months. The data was analyzed by the Statistical Package for the Social Sciences (SPSS) version 25.
Results: The mean age of neonates at presentation was 2.00±0.72 days. Gestational diabetes was diagnosed in the second trimester in 72(66.7%) and the third trimester in 36(33.3%) mothers. Out of 108 females, 12(11.1%) were only on insulin, 76(70.4%) were prescribed metformin only, 16(14.8%) were taking combination of metformin with insulin and 4(3.7%) were on diet control. On echocardiography, patent ductus arteriosus (PDA) was detected in 56(70%) cases, ventricular septal defect (VSD) in 8(10%) neonates, septal hypertrophy with PDA in 8(10%) cases, VSD with PDA in 8(10%) cases while 28(25.9%) had normal cardiac functioning. At follow-up, spontaneous closure of defect occurred in 68(85%) neonates with congenital cardiac defects. On comparison, PDA was significantly more common in neonates of diabetic mothers on metformin (p <0.05).
Conclusion: Neonates born to diabetic mothers had a high frequency of cardiac abnormalities (74%). The risk of cardiac anomalies was significantly high in neonates born to females with GDM who were treated with metformin alone.
References
1. Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH, et al. Epidemiology and management of gestational diabetes. Lancet. 2024; 404(10448):175-92. doi:10.1016/S0140-6736(24)00825-0.
2. Candido R, Toffoli B, Manfredi G, Turisani A, Delfauro V, Petrucco A, et al. Retrospective cohort study on treatment outcomes of early vs late onset gestational diabetes mellitus. Acta Diabetol. 2024. doi:10.1007/s00592-024-02405-y.
3. Adnan M, Aasim M. Prevalence of gestational diabetes mellitus in Pakistan: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024; 24(1):108. doi:10.1186/ s12884-024-06290-9.
4. James-Allan LB, Rosario FJ, Madi L, Barner K, Nair S, Lai A, et al. A novel technique using chronic infusion of small extracellular vesicles from gestational diabetes mellitus causes glucose intolerance in pregnant mice. Clin Sci (Lond). 2022; 136(21):1535-49. doi:10.1042/CS20220484.
5. Szlapinski SK, Hill DJ. Metabolic adaptations to pregnancy in healthy and gestational diabetic pregnancies: the pancreas - placenta axis. Curr Vasc Pharmacol. 2021; 19(2):141-53. doi:10.2174/1570161118666200320111209.
6. Nair S, Ormazabal V, Lappas M, McIntyre HD, Salomon C. Extracellular vesicles and their potential role inducing changes in maternal insulin sensitivity during gestational diabetes mellitus. Am J Reprod Immunol. 2021; 85(2):e13361. doi:10.1111/aji.13361.
7. Seedat F, Kandzija N, Ellis MJ, Jiang S, Sarbalina A, Bancroft J, et al. Placental small extracellular vesicles from normal pregnancy and gestational diabetes increase insulin gene transcription and content in β cells. Clin Sci (Lond). 2024; 138(22):1481-502. doi:10.1042/CS20241782.
8. Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K. Unveiling gestational diabetes: an overview of pathophysiology and management. Int J Mol Sci. 2025; 26(5):2320. doi:10.3390/ijms26052320.
9. Kouhkan A, Najafi L, Malek M, Baradaran HR, Hosseini R, Khajavi A, et al. Gestational diabetes mellitus: major risk factors and pregnancy-related outcomes: a cohort study. Int J Reprod Biomed. 2021; 19(9):827-36. doi:10.18502/ijrm.v19i9.9715.
10. Shamsad A, Kushwah AS, Singh R, Banerjee M. Pharmaco-epi-genetic and patho-physiology of gestational diabetes mellitus (GDM): an overview. Health Sci Rev. 2023; 7:100086. doi:10.1016/j.hsr.2023.100086.
11. Lee KS, Choi YJ, Cho J, Lee H, Lee H, Park SJ, et al. Environmental and genetic risk factors of congenital anomalies: an umbrella review of systematic reviews and meta-analyses. J Korean Med Sci. 2021; 36(28):e183. doi:10.3346/jkms.2021.36.e183.
12. Loeken MR. Mechanisms of congenital malformations in pregnancies with pre-existing diabetes. Curr Diab Rep. 2020; 20(10):54. doi:10.1007/s11892-020-01338-4.
13. Paauw ND, Stegeman R, de Vroede MAMJ, Termote JUM, Freund MW, Breur JMPJ. Neonatal cardiac hypertrophy: the role of hyperinsulinism-a review of literature. Eur J Pediatr. 2020; 179(1):39-50. doi:10.1007/s00431-019-03521-6.
14. Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. A clinical review. Int J Mol Sci. 2021; 22(6):2965. doi:10.3390/ijms22062965.
15. Bayoumy S, Habib M, Abdelmageed R. Impact of maternal diabetes and obesity on fetal cardiac functions. Egypt Heart J. 2020; 72(1):46. doi:10.1186/s43044-020-00077-x.
16. Afridi SB, Khan M, Shaikh M, Shaikh AS. Frequency and pattern of congenital heart defects in infant of diabetic mother at tertiary care hospital. LNJPC. 2023; 5(2):82-6. doi:10.37184/lnjpc.2707-3521.5.17.
17. Arjmandnia MH, Yousefi M, Rezvan S, Vahedian M, Noori E, Mohammadi A, et al. Evaluation of congenital heart diseases in neonates with diabetic mothers who referred to teaching hospitals in Qom, Iran. J Vessel Circ. 2020; 1(1): 33-6. doi:10.29252/jvesselcirc.1.1.33.
18. Sadiq F, Shah SMA, Khan A, Nisar S, Iqbal M, Khan A. Pattern of congenital heart disease in 0 to 28 days infants of diabetic mothers. KJMS. 2024; 17(2):67-70. doi:10.70520/kjms.v17i2.483.
19. Shamaoon M, Zunaira, Ahsan M, Maqbool T, Aslam R, Yaseen A. Congenital heart defects in neonates born to diabetic mother (IDM): a single center experience. Professional Med J. 2020; 27(5):950-6. doi:10.29309/TPMJ/2020.27.05.3924.
20. Andrade C. Exposure of pregnancy to pregestational diabetes, gestational diabetes, and antidiabetic medications with especial focus on major congenital and cardiac malformations in offspring. J Clin Psychiatry. 2024; 85(1):24f15318. doi:10.4088/JCP.24f15318.
21. Al Ghadeer HA, Alherz AH, Albattat FS, Alkhamis MA, Alamer MH, Almulaifi LF, et al. Pattern and frequency of congenital heart defects among infants of diabetic mothers. Cureus. 2024; 16(12):e76184. doi:10.7759/cureus.76184.
22. Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 2022; 11(17):e025784. doi:10.1161/JAHA.122.025784.
23. Nielsen MR, Aldenryd AE, Hagstrom S, Pedersen LM, Brix N. The chance of spontaneous patent ductus arteriosus closure in preterm infants born before 32 weeks of gestation is high and continues to increase until 5 years of follow-up. Acta Paediatr. 2022; 111(12):2322-2330. doi:10.1111/apa.16541.
24. Codazzi AC, Ippolito R, Novara C, Tondina E, Cerbo RM, Tzialla C. Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up. Ital J Pediatr. 2021; 47(1):197. doi:10.1186/ s13052-021-01145-x.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Sharif Medical & Dental College is licensed and distributed under the terms of Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
